Claritev Corp (CTEV)
Claritev Corp is a healthcare technology company listed on the NYSE under the ticker CTEV. Through its subsidiaries, the company provides data analytics and technology-enabled solutions focused on end-to-end cost management, payment integrity, and revenue integrity for the U.S. healthcare industry. Its offerings include claims intelligence tools such as reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions that cover primary and complementary networks as well as network build and management services; and payment and revenue integrity services spanning clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity. Claritev also provides data and analytics products including PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company serves a broad customer base that includes commercial healthcare payers, third-party administrators, employers, brokers and consultants, providers, government healthcare payers, and system integrators. Founded in 1980 and headquartered in McLean, Virginia, it was formerly known as MultiPlan Corporation before changing its name in February 2025.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-CTEV
|
$25.74
|
-10.5% Downside
|
Fair
|
$37.67
|
30.9% Upside
|
Undervalued
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 7, 2026
|
-1.7x
|
-2.0x
|
0.5x
|
513.5 M
|
5.216 B
|
90.1%
|
33.8%
|
-3.4
|
—
|
12.5%
|